Suzane Kioko Ono
Overview
Explore the profile of Suzane Kioko Ono including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naldi G, Minari A, Pereira T, Fossaluza V, Eugenio N, Ferreira M, et al.
Pharmacogenomics J
. 2025 Feb;
25(2):4.
PMID: 39994182
Liver transplantation is the only curative option for patients with advanced stages of liver disease, with tacrolimus used as the immunosuppressive drug of choice. Genetic variability can interfere with drug...
2.
Rocha B, Ferreira L, Vianna L, Ciconelle A, Cortez Filho J, Nogueira L, et al.
Clinics (Sao Paulo)
. 2024 Oct;
79:100512.
PMID: 39388738
Background: Hepatocellular carcinoma (HCC) is a prevalent tumor with high mortality rates. Computed tomography (CT) is crucial in the non-invasive diagnosis of HCC. Recent advancements in artificial intelligence (AI) have...
3.
Paranagua-Vezozzo D, Terrabuio D, Reinoso-Pereira G, Moutinho R, Ono S, Walwyn Salas V, et al.
JGH Open
. 2023 May;
7(4):272-277.
PMID: 37125250
Background And Aim: The aim was to analyze the concordance of liver stiffness measurement (LSM) either by transient elastography (TE) or ARFI with liver biopsy in autoimmune hepatitis (AIH) patients...
4.
Bertolli M, Rocha P, Pinto V, Ono S
Rev Assoc Med Bras (1992)
. 2022 Nov;
68(11):1509-1513.
PMID: 36449766
Objective: Hepatitis B is an important public health concern. Currently, the COVID-19 pandemic is a major challenge for health systems, and the access to pharmacologic and non-pharmacologic treatment of chronic...
5.
Rocha B, Ferreira L, Vianna L, Gomes Ferreira L, Ciconelle A, Da Silva Noronha A, et al.
Sci Rep
. 2022 Nov;
12(1):20315.
PMID: 36434070
Hepatocellular carcinoma (HCC) has become the 4th leading cause of cancer-related deaths, with high social, economical and health implications. Imaging techniques such as multiphase computed tomography (CT) have been successfully...
6.
Reinoso-Pereira G, Paranagua-Vezozzo D, Mazo D, Franca J, Ono S, Carrilho F
Arq Gastroenterol
. 2022 Jul;
59(2):204-211.
PMID: 35830030
Background: Evaluate the role of liver stiffness measurement (LSM) by transient elastography (TE) as a risk factor for hepatocellular carcinoma (HCC) occurrence in a prospective cohort of Brazilian hepatitis C...
7.
Bin K, Melo A, da Rocha J, de Almeida R, Cobello Junior V, Maia F, et al.
JMIR Form Res
. 2022 Feb;
6(2):e29012.
PMID: 35103611
Background: To demonstrate the value of implementation of an artificial intelligence solution in health care service, a winning project of the Massachusetts Institute of Technology Hacking Medicine Brazil competition was...
8.
Bassit L, Ono S, Schinazi R
Adv Exp Med Biol
. 2021 Jul;
1322:115-138.
PMID: 34258739
Currently, there are two safe and effective therapeutic strategies for chronic hepatitis B treatment, namely, nucleoside analogs and interferon alpha (pegylated or non-pegylated). These treatments can control viral replication and...
9.
Bin K, Higa N, da Silva J, Quagliano D, Hangai R, Cobello-Junior V, et al.
Clinics (Sao Paulo)
. 2021 Jun;
76:e2795.
PMID: 34133480
Objectives: A good health care does not only depend on good medical practice, but also needs great management of its resources, which are generally short. In this sense, PROAHSA has...
10.
Bessone F, Hernandez N, Mendizabal M, Ridruejo E, Gualano G, Fassio E, et al.
Arch Toxicol
. 2021 Mar;
95(4):1475-1487.
PMID: 33759010
Nimesulide is a non-steroidal anti-inflammatory drug still marketed in many countries. We aim to analyze the clinical phenotype, outcome, and histological features of nimesulide-induced liver injury (nimesulide-DILI). We analyzed 57...